Annual CFO
-$73.65 M
+$13.45 M+15.44%
December 31, 2023
Summary
- As of February 8, 2025, OMIC annual cash flow from operations is -$73.65 million, with the most recent change of +$13.45 million (+15.44%) on December 31, 2023.
- During the last 3 years, OMIC annual CFO has fallen by -$48.77 million (-196.09%).
- OMIC annual CFO is now -546.08% below its all-time high of -$11.40 million, reached on December 31, 2019.
Performance
OMIC Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$19.79 M
-$1.75 M-9.70%
September 30, 2024
Summary
- As of February 8, 2025, OMIC quarterly cash flow from operations is -$19.79 million, with the most recent change of -$1.75 million (-9.70%) on September 30, 2024.
- Over the past year, OMIC quarterly CFO has dropped by -$886.00 thousand (-4.69%).
- OMIC quarterly CFO is now -320.22% below its all-time high of -$4.71 million, reached on March 1, 2020.
Performance
OMIC Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$80.43 M
-$2.98 M-3.84%
September 30, 2024
Summary
- As of February 8, 2025, OMIC TTM cash flow from operations is -$80.43 million, with the most recent change of -$2.98 million (-3.84%) on September 30, 2024.
- Over the past year, OMIC TTM CFO has dropped by -$6.78 million (-9.21%).
- OMIC TTM CFO is now -1608.03% below its all-time high of -$4.71 million, reached on March 1, 2020.
Performance
OMIC TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
OMIC Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.4% | -4.7% | -9.2% |
| 3 y3 years | -196.1% | -4.7% | -9.2% |
| 5 y5 years | -546.1% | -4.7% | -9.2% |
OMIC Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -42.5% | +15.4% | -26.1% | +22.6% | -55.6% | +7.7% |
| 5 y | 5-year | -546.1% | +15.4% | -320.2% | +22.6% | -1608.0% | +7.7% |
| alltime | all time | -546.1% | +15.4% | -320.2% | +22.6% | -1608.0% | +7.7% |
Singular Genomics Systems Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$19.79 M(+9.7%) | -$80.43 M(+3.8%) |
| Jun 2024 | - | -$18.04 M(-23.9%) | -$77.46 M(-2.5%) |
| Mar 2024 | - | -$23.70 M(+25.4%) | -$79.42 M(+7.8%) |
| Dec 2023 | -$73.65 M(-15.4%) | -$18.90 M(+12.4%) | -$73.65 M(-1.4%) |
| Sep 2023 | - | -$16.81 M(-15.9%) | -$74.66 M(-6.2%) |
| Jun 2023 | - | -$20.00 M(+11.5%) | -$79.64 M(-6.5%) |
| Mar 2023 | - | -$17.93 M(-10.0%) | -$85.19 M(-2.2%) |
| Dec 2022 | -$87.09 M | -$19.92 M(-8.6%) | -$87.09 M(+5.1%) |
| Sep 2022 | - | -$21.79 M(-14.7%) | -$82.88 M(+15.0%) |
| Jun 2022 | - | -$25.55 M(+28.8%) | -$72.07 M(+15.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$19.84 M(+26.4%) | -$62.35 M(+20.6%) |
| Dec 2021 | -$51.70 M(+107.9%) | -$15.70 M(+43.0%) | -$51.70 M(+20.3%) |
| Sep 2021 | - | -$10.98 M(-30.7%) | -$42.99 M(+11.1%) |
| Jun 2021 | - | -$15.84 M(+72.5%) | -$38.68 M(+31.8%) |
| Mar 2021 | - | -$9.19 M(+31.5%) | -$29.35 M(+18.0%) |
| Dec 2020 | -$24.87 M(+118.2%) | -$6.99 M(+4.8%) | -$24.87 M(+39.1%) |
| Sep 2020 | - | -$6.67 M(+2.3%) | -$17.89 M(+59.4%) |
| Jun 2020 | - | -$6.51 M(+38.3%) | -$11.22 M(+138.3%) |
| Mar 2020 | - | -$4.71 M | -$4.71 M |
| Dec 2019 | -$11.40 M | - | - |
FAQ
- What is Singular Genomics Systems annual cash flow from operations?
- What is the all time high annual CFO for Singular Genomics Systems?
- What is Singular Genomics Systems annual CFO year-on-year change?
- What is Singular Genomics Systems quarterly cash flow from operations?
- What is the all time high quarterly CFO for Singular Genomics Systems?
- What is Singular Genomics Systems quarterly CFO year-on-year change?
- What is Singular Genomics Systems TTM cash flow from operations?
- What is the all time high TTM CFO for Singular Genomics Systems?
- What is Singular Genomics Systems TTM CFO year-on-year change?
What is Singular Genomics Systems annual cash flow from operations?
The current annual CFO of OMIC is -$73.65 M
What is the all time high annual CFO for Singular Genomics Systems?
Singular Genomics Systems all-time high annual cash flow from operations is -$11.40 M
What is Singular Genomics Systems annual CFO year-on-year change?
Over the past year, OMIC annual cash flow from operations has changed by +$13.45 M (+15.44%)
What is Singular Genomics Systems quarterly cash flow from operations?
The current quarterly CFO of OMIC is -$19.79 M
What is the all time high quarterly CFO for Singular Genomics Systems?
Singular Genomics Systems all-time high quarterly cash flow from operations is -$4.71 M
What is Singular Genomics Systems quarterly CFO year-on-year change?
Over the past year, OMIC quarterly cash flow from operations has changed by -$886.00 K (-4.69%)
What is Singular Genomics Systems TTM cash flow from operations?
The current TTM CFO of OMIC is -$80.43 M
What is the all time high TTM CFO for Singular Genomics Systems?
Singular Genomics Systems all-time high TTM cash flow from operations is -$4.71 M
What is Singular Genomics Systems TTM CFO year-on-year change?
Over the past year, OMIC TTM cash flow from operations has changed by -$6.78 M (-9.21%)